
“Enveric Biosciences Successfully Closes $5 Million Public Offering: A Promising Step Towards Advancing Medical Breakthroughs”
Enveric Biosciences Announces Closing of Public Offering About Enveric Biosciences Enveric Biosciences, Inc. is a biotechnology company based in Cambridge, Massachusetts. The company is focused on developing innovative neuroplastogenic small-molecule therapeutics to address anxiety, depression, and addiction disorders. Public Offering Details Enveric Biosciences recently completed a public offering of 1,666,666 shares of its common stock….